RET and medullary thyroid gland carcinoma: An interesting finding was that relatives whose diagnoses of MTC/CCH were made after RET screening had lower sCt levels and less frequent postsurgical hypoparathyroidism than index patients and mutation-carrier relatives whose diagnoses of MTC/CCH were made before RET screening (p < 0.05) (Table 3).